Literature DB >> 33496235

Prevalence of SARS-CoV-2-Specific Antibodies, Japan, June 2020.

Takashi Yoshiyama, Yasuki Saito, Kunitsugu Masuda, Yoshiko Nakanishi, Yasutoshi Kido, Kazuhiro Uchimura, Satoshi Mitarai, Tadaki Suzuki, Yu Nakagama, Hiroshi Kubota, Maki Satomi, Sana Uchikoba, Makoto Ohnishi, Takaji Wakita, Seiya Kato, Katsunobu Kato.   

Abstract

We used 2 commercially available antibody tests to estimate seroprevalence of severe acute respiratory syndrome coronavirus 2 infection in Japan during June 2020. Of 7,950 samples, 8 were positive by both assays. Using 2 reliable antibody tests in conjunction is an effective method for estimating seroprevalence in low prevalence settings.

Entities:  

Keywords:  2019 novel coronavirus disease; COVID-19; Japan; SARS-CoV-2; antibodies; antibody responses; coronavirus; coronavirus disease; diagnostics; immunology; respiratory infections; serology; seroprevalence; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses

Mesh：

Substances：

Year:  2021        PMID： 33496235     DOI： 10.3201/eid2702.204088

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN： 1080-6040            Impact factor:   6.883


  3 in total

1.  SARS-CoV-2 seroprevalence in healthcare workers at a frontline hospital in Tokyo.

Authors:  Hiroshi Fukuda; Kuniaki Seyama; Kanami Ito; Tomohiko Ai; Shuko Nojiri; Satoshi Hori; Mitsuru Wakita; Kaori Saito; Yuka Shida; Rie Nagura; Mayu Hasegawa; Chiaki Kanemoto; Mayumi Tokuhara; Katsunobu Okajima; Yukio Yoshikawa; Narimasa Katsuta; Takamasa Yamamoto; Mayumi Idei; Yuki Horiuchi; Kotoko Yamatani; Shigeki Misawa; Toshio Naito; Takashi Miida; Hiroyuki Sato; Nobutaka Hattori; Yoko Tabe; Kazuhisa Takahashi
Journal:  Sci Rep       Date:  2021-04-16       Impact factor: 4.379

2.  Mass SARS-CoV-2 serological screening, a population-based study in the Principality of Andorra.

Authors:  Cristina Royo-Cebrecos; David Vilanova; Joel López; Vanesa Arroyo; Marc Pons; Guillem Francisco; Mireia G Carrasco; Josep M Piqué; Sergi Sanz; Carlota Dobaño; Alberto L García-Basteiro
Journal:  Lancet Reg Health Eur       Date:  2021-05-21

3.  Inferring the true number of SARS-CoV-2 infections in Japan.

Authors:  Lauren McKenzie; Affan Shoukat; Kai On Wong; Koju Itahashi; Eiji Yasuda; Alex Demarsh; Kamran Khan
Journal:  J Infect Chemother       Date:  2022-08-09       Impact factor: 2.065
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.